椎体骨折资源利用与费用的描述:B3E预试验
该探索性经济分析纳入141例≥65岁、经X线确诊椎体骨折的女性,随机分入12个月家庭锻炼项目组或等量关注对照组,采集健康资源利用与费用及EQ-5D-5L生活质量。结果显示干预组总费用与均值费用均高于对照组,但不良事件费用较低,ICER为29,650加元/QALY。
要点
- 主要费用驱动为照护者时间、药物和不良事件。
- 干预组均值费用9365±9988加元,高于对照组8772±9718加元。
- 干预组EQ-5D指数0.81±0.11,高于对照组0.79±0.13。
核心结论
- 骨质疏松伴既往骨折女性经历多种资源利用和相关费用,影响其照护与生活质量。
- 照护者时间、药物和不良事件是该人群最大的费用驱动因素。
- 添加锻炼项目可能降低不良事件风险。
研究设计与样本
- 探索性经济分析,基于B3E预试验。
- ≥65岁、有1处及以上X线确诊椎体骨折的女性141例,1:1随机分为12个月家庭锻炼项目组或等量关注对照组。
- 通过每月电话和参与者每日日记收集临床与健康系统资源,并纳入干预成本;健康系统资源应用单位成本。
- 基线、6个月和12个月通过EQ-5D-5L收集生活质量信息。
主要发现
- 总费用(2018加元):干预组664,923加元,对照组614,033加元。
- 前三位费用驱动:照护者时间(干预组250,269加元,对照组240,811加元)、药物(151,000加元 vs 122,145加元)、不良事件(58,807加元 vs 71,981加元)。
- 每名干预参与者均值费用9365±9988加元,高于对照组的8772±9718加元。
- 干预组平均EQ-5D指数0.81±0.11,高于对照组0.79±0.13。
- QALY差异0.02与均值费用差异593加元用于计算ICER,结果为29,650加元。
关键数值与推荐
- QALY差异为0.02,均值费用差异为593加元,ICER为29,650加元。
临床怎么用
- 在评估骨质疏松椎体骨折患者照护成本时,应关注照护者时间、药物和不良事件等主要费用驱动。
- 家庭锻炼项目可能降低不良事件风险,但均值费用更高,决策时需结合ICER评估经济性。
局限性
- 为探索性经济分析,基于预试验。
- 样本量141例,随访12个月。
- 作者指出下一步需扩大样本量、延长随访并增加区域多样性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This analysis examined costs/resources of 141 women with vertebral fractures, randomised to a home exercise programme or control group. Total, mean costs and the incremental cost-effectiveness ratio (ICER) were calculated. Quality of life was collected. Cost drivers were caregiver time, medications and adverse events (AEs). Results show adding an exercise programme may reduce the risk of AEs. INTRODUCTION: This exploratory economic analysis examined the health resource utilisation and costs experienced by women with vertebral fractures, and explored the effects of home exercise on those costs. METHODS: Women ≥ 65 years with one or more X-ray-confirmed vertebral fractures were randomised 1:1 to a 12-month home exercise programme or equal attention control group. Clinical and health system resources were collected during monthly phone calls and daily diaries completed by participants. Intervention costs were included. Unit costs were applied to health system resources. Quality of life (QoL) information was collected via EQ-5D-5L at baseline, 6 and 12 months. RESULTS: One hundred and forty-one women were randomised. Overall total costs (CAD 2018) were $664,923 (intervention) and $614,033 (control), respectively. The top three cost drivers were caregiver time ($250,269 and $240,811), medications ($151,000 and $122,145) and AEs ($58,807 and $71,981). The mean cost per intervention participant of $9365 ± $9988 was higher compared with the mean cost per control participant of $8772 ± $9718. The mean EQ-5D index score was higher for the intervention participants (0.81 ± 0.11) compared with that of controls (0.79 ± 0.13). The differences in quality-adjusted life year (QALY) (0.02) and mean cost ($593) were used to calculate the ICER of $29,650. CONCLUSIONS: Women with osteoporosis with a previous fracture experience a number of resources and associated costs that impact their care and quality of life. Caregiver time, medications and AEs are the biggest cost drivers for this population. The next steps would be to expand this feasibility study with more participants, longer-term follow-up and more regional variability.
引用
- Hassan S, Seung SJ, Clark RE, et al. Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot Trial. Osteoporos Int. 2020. PMID: 32219499. doi:10.1007/s00198-020-05387-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。